No profile data available.
Scinai Immunotherapeutics Ltd. (SCNI) is a healthcare company in the drug manufacturing contractors industry, based in Jerusalem, Israel, with about 45 full-time employees.
It reported revenue of $1.31 million for fiscal year 2025, up 99.2% from fiscal year 2024, and net income of $0. Its market capitalization was $1.60 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally.
Scinai Immunotherapeutics reported $1.31 million in revenue for fiscal year 2025, up 99.2% from $658,000 in fiscal year 2024.
$1.60 million as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Pluri Inc. (PLUR), Bio Green Med Solution, Inc. (BGMS), Orgenesis Inc. (ORGS), Qian Yuan Baixing, Inc. (QYBX).